At the workshop, experts will review evidence on the potential benefits of probiotics and other products containing live bacteria to help treat certain medical conditions, such as neonatal necrotizing enterocolitis.
While there is growing interest within the healthcare industry about the use of probiotics, some health experts said they feel more research is required to ensure the products’ safety and efficacy.
Pieter Cohen, MD, assistant professor at Boston-based Harvard Medical School who studies supplements, told STAT he hopes “the FDA will focus on how to modernize its antiquated approach to ensuring probiotic safety and ensure that only high-quality products are available to consumers.”
More articles on clinical leadership and infection control:
Alaska psych hospital prioritizes patient safety over staff, employees say
‘Vampire facial’ puts New Mexico spa clients at risk of HIV, hepatitis
FDA proposes antibiotic subscription plan for hospitals
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.